GangaGen Inc.

GangaGen is developing treatments for bacterial infections.

Facts from the Community

From the BioVenturist base

Investment Round:

Investment round Amount raised Date Investors
  • 1,800,000
  • Oct 7, 2008
  • 5,400,000
  • Nov 24, 2008
View entire collection »
top ↑

We can tell you that GangaGen Inc. is a…

If you know more about GangaGen Inc., you can add more facts here »

Similar topics in Freebase

  • Ironwood Pharmaceuticals Inc.

    Ironwood Pharmaceuticals Inc.

  • TaiGen Biotechnology Co.

    TaiGen Biotechnology Co.

    TaiGen is a Taiwan based therapeutic developer focused on treatments for cancer, infectious disease, and diabetic complications.
  • MicroPhage Inc.

    MicroPhage Inc.

    MicroPhage is developing rapid bacterial diagnostics, focused on bacterial identification and antbiotic susceptibility.
  • Bayer

    Bayer

    Bayer AG (German pronunciation: [ˈbaɪə]) (FWB: BAY, TYO: 4863) is a German chemical and pharmaceutical company founded in Barmen, Germany in 1863. Today it is headquartered in Leverkusen, North Rhine-Westphalia, Germany. It is well-known for its original brand of aspirin. Bayer is the third largest...
  • Rib-X Pharmaceuticals

    Rib-X Pharmaceuticals

    Rib-X Pharmaceuticals, Inc. is a privately-held New Haven, Connecticut based development-stage biopharmaceutical company, founded in 2001 to develop small-molecule antibiotics to treat serious multi-drug resistant bacterial infections. Rib-X's compounds (two of which are in Phase 2 clinical trials)...
  • Johnson & Johnson

    Johnson & Johnson

    Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its...
  • Anacor Pharmaceuticals Inc.

    Anacor Pharmaceuticals Inc.

    Anacor Pharmaceuticals is developing small-molecule therapeutics using their boron chemistry platform.
  • Mpex Pharmaceuticals Inc.

    Mpex is developing new therapeutics to combat antibiotic resistant bacteria, with a particular focus on gram-negative organisms.
  • QLT Inc.

  • Lytix Biopharma

    Lytix Biopharma is developing lytic peptide therapeutics for resistant bacterial and fungal infections, as well as for oncology.

These people have edited this topic:

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

Learn more about Freebase licensing and attribution